Author Archives: Nick Corbishley

Remittances to Latin America Surge, Even As Virus Crisis Continues to Bite in Host Economies

One of the rare economic success stories of the past year. But there are also downsides and dark sides to the remittances story.

Vaccine Certificates Are Making Global Travel Harder, Not Easier

Vaccine certificates were ostensibly rolled out to help facilitate cross-border travel as vaccination numbers increased. But thanks to vaccine geopolitics, the opposite is happening

Does the Fate of Ivermectin As a Covid-19 Treatment Rest in the Hands of the Deeply Conflicted Bill & Melinda Gates Foundation?

One of the world’s biggest vaccine proponents and strident defender of intellectual property rights is funding, directly and indirectly, large trials into cheap, off-patent, off-label COVID-19 treatments, including ivermectin.

A Worrying Trend Emerges in South America, As Right-Wing Populists Take A Leaf Out of Trump and Netanyahu’s Playbook

If the elected leaders of long-established democracies like the US and Israel can question the workings of their electoral system, why can’t others of less-established ones?

Tourism Begins to Recover in Europe, But Is It Just a Dead Cat Bounce?

Warning signs are already flashing that Europe’s reopening to the outside world may be short lived.

Is Another Military Coup Brewing in Peru, After Historic Electoral Victory for Leftist Candidate?

The threat should not be taken lightly, especially given Peru’s long history of coups d’états.

First UK Inquiry Into Greensill Scandal Calls for Extension to Lobbying Ban for Former Ministers and Civil Servants

The inquiry also recommends greater transparency and accountability from the government. Unfortunately, the trend is in the opposite direction.

WHO Celebrates As Indian Health Regulator Removes Ivermectin from Its Covid-19 Protocol

After India finally gets somewhat of a grip on its deadly second wave, one of its health regulators just took away one of its main lines of defense.

The Empire Strikes Back Against Mexican President AMLO

As The Economist urges Mexican voters to vote for anyone who isn’t AMLO, the US government is up to its old tricks: funneling money to political opposition groups.

“I Don’t Know of a Bigger Story in the World” Right Now Than Ivermectin: NY Times Best-Selling Author

So why are journalists not covering it?

More Bad Omens for Business Travel, As WEF Axes Tropical Davos and Mobile World Congress Suffers Wave of Cancellations

The cancellation of the World Economic Forum’s Singapore meeting and the gathering exodus of participants from the World Mobile Congress in Barcelona do not bode well for the near-term future of business travel.

Bayer-Monsanto Fails (At First Attempt) to Block Mexico’s Phaseout of Glyphosate and Ban on GMO Corn

Mexico has already gone mano a mano with Monsanto before, and it came out on top. But this time it’s on a direct collision course with Big Ag and the U.S. government.

India Just Became Latest Country to Approve Use of Ivermectin to Treat Covid-19

There are now more than 20 countries on the planet that are using the off-patent anti-parasite drug against Covid-19.

Mexico’s AMLO Locks Horns With Business Elite As Make-or-Break Elections Loom

Long-simmering tensions between government and business interests escalate in the run-up to the country’s biggest ever midterm elections.

Europe’s Eminence Grise, BlackRock, Is Helping to Write Europe’s Sustainable Banking Rules. What Could Go Wrong?

Despite facing accusations of rampant greenwashing, BlackRock is once again in the driving seat of public policy in Europe. But its potential conflicts of interest are at least finally attracting a little attention.